Literature DB >> 9241553

The importance of visual erotic stimulation in the differential diagnosis of erectile impotence.

S Aydoğan1, M K Bircan, H Sahin, K Korkmaz.   

Abstract

In this study we aimed to determine the importance of visual erotic stimulation (VES) alone, and in combination with intracavernosal papaverine injection (ICPE) in the differential diagnosis of erectile impotence. Sixty-four patients with erection problems were investigated between June 1992 and January 1994. VES could be the first investigative method in the differential diagnosis of erectile impotence. This will help us in some groups of patients with psychogenic impotence to avoid the application and complications of ICPE. In patients with insufficient erections with VES alone, ICPE must be combined with VES in order to detect the causes of psychogenic erectile impotence more correctly.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9241553     DOI: 10.1007/bf02551347

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  5 in total

1.  Erectile response to visual erotic stimuli before and after intracavernosal papaverine, and its relationship to nocturnal penile tumescence and psychometric assessment.

Authors:  J Bancroft; G Smith; M Munoz; P Ronald
Journal:  Br J Urol       Date:  1991-12

2.  Impotence evaluation.

Authors:  W D Steers
Journal:  J Urol       Date:  1993-05       Impact factor: 7.450

3.  Potentiation of drug-induced erection with audiovisual sexual stimulation.

Authors:  N M Katlowitz; G J Albano; P Morales; M Golimbu
Journal:  Urology       Date:  1993-05       Impact factor: 2.649

4.  Erection problems in medical practice: differential diagnosis with relatively simple method.

Authors:  A K Slob; J H Blom; J J van der Werff ten Bosch
Journal:  J Urol       Date:  1990-01       Impact factor: 7.450

5.  Predictive value of real-time RigiScan monitoring for the etiology of organogenic impotence.

Authors:  M Djamilian; C G Stief; U Hartmann; U Jonas
Journal:  J Urol       Date:  1993-05       Impact factor: 7.450

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.